Adam Marcus

Paper on sexual orientation and neuropsychiatric disorders earns an expression of concern

Dick Swaab By Sxologist Wikipedia – , CC BY 2.0

An Elsevier journal has issued an expression of concern for a paper it published earlier this year by a Dutch researcher who studies the neurobiology of sexuality.

The article,“Sexual orientation, neuropsychiatric disorders and the neurotransmitters involved,” was written by a group led by Dick Swaab, of the Department of Neuropsychiatric Disorders at the Netherlands Institute for Neuroscience in Amsterdam.

The abstract of the latest study reads:

Pentagon-funded Duke research on soldier brain damage under investigation

Duke University is investigating potential misconduct in a trio of studies of ways to identify brain damage in soldiers.

The studies were conducted by Mohamed B Abou-Donia and Brahmajothi Mulugu, and appeared in the February 2020 issue of Military Medicine, which has issued an expression of concern about the articles. The research was performed using funding from the U.S. Department of Defense; two of the studies were presented as posters at the 2018 Military Health System Research Symposium.

Dr. Mulugu is listed as a research scientist in the Department of Pediatrics at Duke. Abou-Donia, who has been at the institution for nearly 50 years, is a professor of pharmacology, cancer biology and neurobiology.

The three papers are:

AHA “regrets any confusion” and is reviewing meeting policies after outcry over Covid-19 vaccine abstract

Days after a leading heart journal issued an expression of concern for a meeting abstract suggesting that vaccines against Covid-19 may cause cardiac damage, its publisher, the American Heart Association (AHA), says it is reviewing how it screens such submissions.

As we reported late last month, “Mrna COVID Vaccines Dramatically Increase Endothelial Inflammatory Markers and ACS Risk as Measured by the PULS Cardiac Test: a Warning,” was presented at the AHA’s 2021 Scientific Sessions in mid-November and was published in Circulation.

The author was Steven Gundry, a cardiac surgeon by training who now sells dietary supplements on his website. Gundry also sees patients at the Center for Restorative Medicine and International Heart & Lung Institute in California and offers advice on YouTube. (His critics say what Gundry peddles costs much more than it’s worth.)

After an outcry, Circulation flagged the published poster with the following notice:

Engineering researcher who suddenly left postdoc has ninth paper retracted

An author with ties to researchers believed to have published hundreds of problematic papers has earned his ninth retraction, this time for forged authorship.

Mostafa Jalal, once a postdoc at Texas A&M University, is alleged to have “engaged in some manner of collaboration or communication” with three other researchers, including Ali Nazari, who has now had 85 papers retracted and lost his job at Swinburne University in 2019. Those retractions came after the whistleblower, the pseudonymous Artemisia Stricta, called attention to problems in Nazari’s work.

In a 42-page report we wrote about in August 2020, Artemisia drew attention to four main groups centered on Jalal, Nazari, Ehsan Mohseni of the University of Newcastle in Australia, and Alireza Najigivi of Sharif University of Technology in Tehran. The whistleblower lists a total of 287 potentially compromised papers.

Authors retract, resubmit “very poorly conducted” meta-analysis of COVID-19 treatment

A journal has retracted a meta-analysis on Covid-19 after concerned readers complained about the quality — or lack thereof — of the study.

The article, “A meta-analysis of granulocyte-macrophage colony-stimulating factor (GM-CSF) antibody treatment for COVID-19 patients,” appeared in Therapeutic Advances in Chronic Disease, a SAGE title.

According to the retraction notice:

Abstract linking COVID-19 vaccines to heart trouble risk earns expression of concern

A leading heart journal has issued an expression of concern for a meeting abstract it published earlier this year by a cardiac surgeon who sells dietary supplements of questionable utility.

The case is the second involving a recent meeting of the American Heart Association.

The abstract, titled “Mrna COVID Vaccines Dramatically Increase Endothelial Inflammatory Markers and ACS Risk as Measured by the PULS Cardiac Test: a Warning,” was presented at the AHA’s 2021 Scientific Sessions in mid-November and was published in Circulation.

But critics have accused Gundry of peddling worthless — if ultimately expensive — advice.

Journal retracts three papers — including two on COVID-19 — because ‘trainee editor’ committed misconduct

A psychiatry journal has retracted two papers on Covid-19 and mental health, and a third on racism, after concluding that an author on the articles rigged the peer-review process.

The papers, which appeared in the International Journal of Social Psychiatry (IJSP), were co-authored by Debanjan Banerjee, then geriactric psychiatrist at the National Institute of Mental Health and Neurosciences in Bengaluru, and his colleagues.

Banerjee, who has since left the institution, was also until recently a “trainee editor” at the journal, as Neuroskeptic noted on Twitter last week, as well as an associate editor of the Journal of Psychosexual Health — both of which are SAGE titles. He’s also an associate editor for the Frontiers journal Aging Psychiatry.

According to the IJSP:

Nanotech paper retracted for duplicated images

Researchers in the United States and Singapore have lost a 2016 article in Science Advances after some of the group learned that one of their colleagues appears to have used duplicated images in the work.

The article, “A universal cooperative assembly-directed method for coating of mesoporous TiO2 nanoshells with enhanced lithium storage properties,” was written by Bu Yuan Guan, then of the School of Chemical and Biomedical Engineering, Nanyang Technological University, along with colleagues at that institution and Ju Li, of the Department of Nuclear Science and Engineering and the Department of Materials Science and Engineering at the Massachusetts Institute of Technology.

The paper has been cited 167 times, according to Clarivate Analytics’ Web of Science.

According to the retraction notice:

Group’s second paper on potential treatments for COVID-19 is retracted

A group of researchers in Egypt have lost a second paper on possible treatments for Covid-19 after questions were raised about the legitimacy of their trial findings — and additional retractions might be coming soon.

As we reported in September, the group lost an article in Scientific Reports about a purported trial comparing favipiravir and hydroxychloroquine to treat the infection.

That move followed an expression of concern, issued in early August, for a paper in the Archives of Virology by Dabbous and his colleagues about favipiravir, titled “Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study.”

The journal has now retracted the article:

Journal mulls expression of concern for Cassava Sciences paper

A journal is considering issuing an expression of concern for a 2005 paper by authors tied to a company that’s now under investigation for fraud, Retraction Watch has learned.

[See an update on this post (bottom).]

The article, “Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor–G protein coupling and Gβγ signaling,” was written by a group linked to Pain Therapeutics, Inc., which in 2019 changed its name to Cassava Sciences.

Last week, the Wall Street Journal reported that the U.S. Securities and Exchange Commission and the National Institutes of Health were investigating claims that the company manipulated data for simulfilam, its experimental drug for Alzheimer’s disease.

As we reported in August, a law firm submitted a “citizen’s petition” to the FDA citing:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this: